Top compounds associated with response to B4GALNT3


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.11 0.001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.1 0.002
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.15 0.002
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.099 0.003
mRNA GW843682X GDSC1000 pan-cancer AAC -0.15 0.003
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.15 0.003
mRNA SN-38 GDSC1000 pan-cancer AAC -0.095 0.004
mRNA L-685458 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
Download CSV